Name : Parvathi N(55Y/F)

Date : 26 Dec 2024

Test Asked : Wellsense Basic

Report Status: Complete Report

PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159, Bangalore

NAME : PARVATHI N(55Y/F) HOME COLLECTION :

REF. BY : SELF
129 v k gokak road Rayasandra Eshwari
TEST ASKED : WELLSENSE BASIC contractors 560099

Report Availability Summary

Note: Please refer to the table below for status of your tests.

8 Ready 0 Ready with Cancellation 0 Processing 0 Cancelled in Lab

TEST DETAILS REPORT STATUS

WELLSENSE BASIC Ready

TSH - ULTRASENSITIVE Ready

HBA PROFILE Ready

HEMOGRAM - 6 PART (DIFF) Ready

LIVER FUNCTION TESTS Ready

IRON DEFICIENCY PROFILE Ready

KIDPRO Ready

LIPID PROFILE Ready

VITAMIN D TOTAL AND B12 COMBO Ready

PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159, Bangalore

NAME : PARVATHI N(55Y/F) HOME COLLECTION :

REF. BY : SELF 129 v k gokak road Rayasandra Eshwari contractors
TEST ASKED : WELLSENSE BASIC 560099

Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
CARDIAC RISK MARKERS
TRIG / HDL RATIO 3.4 Ratio < 3.12
COMPLETE HEMOGRAM
HEMOGLOBIN 11.7 g/dL 12.0-15.0
MEAN CORP.HEMO.CONC(MCHC) 31.3 g/dL 31.5-34.5
MEAN CORPUSCULAR HEMOGLOBIN(MCH) 25.1 pq 27.0-32.0
MEAN CORPUSCULAR VOLUME(MCV) 80.3 fL 83.0-101.0
RED CELL DISTRIBUTION WIDTH (RDW-CV) 14.6 % 11.6-14.0
DIABETES
AVERAGE BLOOD GLUCOSE (ABG) 157 mg/dL 90-120
HbA1c 7.1 % < 5.7
IRON DEFICIENCY
% TRANSFERRIN SATURATION 6.11 % 13 - 45
IRON 28.88 µg/dL 50 - 170
UNSAT.IRON-BINDING CAPACITY(UIBC) 443.6 µg/dL 162 - 368
LIPID
HDL / LDL RATIO 0.23 Ratio > 0.40
HDL CHOLESTEROL - DIRECT 37 mg/dL 40-60
LDL / HDL RATIO 4.3 Ratio 1.5-3.5
LDL CHOLESTEROL - DIRECT 158 mg/dL < 100
NON-HDL CHOLESTEROL 183.8 mg/dL < 160
TC/ HDL CHOLESTEROL RATIO 5.9 Ratio 3-5
TOTAL CHOLESTEROL 221 mg/dL < 200
LIVER
SERUM GLOBULIN 4 gm/dL 2.5-3.4
RENAL
CREATININE - SERUM 0.46 mg/dL 0.55-1.02
VITAMINS
25-OH VITAMIN D (TOTAL) 24.6 ng/mL 30-100
VITAMIN B-12 1226 pg/mL 211-911

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159,
Bangalore

NAME : PARVATHI N(55Y/F) HOME COLLECTION :

REF. BY 129 v k gokak road Rayasandra Eshwari
: SELF
contractors 560099
TEST ASKED : WELLSENSE BASIC

TEST NAME TECHNOLOGY VALUE UNITS

HbA1c - (HPLC)
H.P.L.C 7.1 %
Bio. Ref. Interval. :

Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control

Method : Fully Automated H.P.L.C method

AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 157 mg/dL
Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control

Method : Derived from HBA1c values

Please correlate with clinical conditions.

Sample Collected on (SCT) : 26 Dec 2024 10:16

Sample Received on (SRT) : 26 Dec 2024 12:23

Report Released on (RRT) : 26 Dec 2024 14:12
Sample Type : EDTA Whole Blood
Labcode : 2612071653/PP004 Dr Ishant Anand MD(Path)
Barcode : DC635634
Page : 1 of 10
PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159,
Bangalore

NAME : PARVATHI N(55Y/F) HOME COLLECTION :

REF. BY : SELF 129 v k gokak road Rayasandra Eshwari
contractors 560099
TEST ASKED : WELLSENSE BASIC

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

HEMOGLOBIN SLS-Hemoglobin Method 11.7 g/dL 12.0-15.0
Hematocrit (PCV) CPH Detection 37.4 % 36.0-46.0
Total RBC HF & EI 4.66 X 10^6/µL 3.8-4.8
Mean Corpuscular Volume (MCV) Calculated 80.3 fL 83.0-101.0
Mean Corpuscular Hemoglobin (MCH) Calculated 25.1 pq 27.0-32.0
Mean Corp.Hemo. Conc (MCHC) Calculated 31.3 g/dL 31.5-34.5
Red Cell Distribution Width - SD (RDW-SD) Calculated 42 fL 39.0-46.0
Red Cell Distribution Width (RDW - CV) Calculated 14.6 % 11.6-14.0
RED CELL DISTRIBUTION WIDTH INDEX (RDWI) Calculated 251.6 - *Refer Note below
MENTZER INDEX Calculated 17.2 - *Refer Note below
TOTAL LEUCOCYTE COUNT (WBC) HF & FC 9.02 X 10³ / µL 4.0 - 10.0
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils Percentage Flow Cytometry 62.5 % 40-80
Lymphocytes Percentage Flow Cytometry 28.5 % 20-40
Monocytes Percentage Flow Cytometry 4.7 % 2-10
Eosinophils Percentage Flow Cytometry 4 % 1-6
Basophils Percentage Flow Cytometry 0.4 % 0-2
Immature Granulocyte Percentage (IG%) Flow Cytometry 0.3 % 0.0-0.4
Nucleated Red Blood Cells % Flow Cytometry 0.01 % 0.0-5.0
ABSOLUTE LEUCOCYTE COUNT
Neutrophils - Absolute Count Calculated 5.64 X 10³ / µL 2.0-7.0
Lymphocytes - Absolute Count Calculated 2.57 X 10³ / µL 1.0-3.0
Monocytes - Absolute Count Calculated 0.42 X 10³ / µL 0.2 - 1.0
Basophils - Absolute Count Calculated 0.04 X 10³ / µL 0.02 - 0.1
Eosinophils - Absolute Count Calculated 0.36 X 10³ / µL 0.02 - 0.5
Immature Granulocytes (IG) Calculated 0.03 X 10³ / µL 0.0-0.3
Nucleated Red Blood Cells Calculated 0.01 X 10³ / µL 0.0-0.5
PLATELET COUNT HF & EI 397 X 10³ / µL 150-410
Mean Platelet Volume (MPV) Calculated 9.7 fL 6.5-12
Platelet Distribution Width (PDW) Calculated 10 fL 9.6-15.2
Platelet to Large Cell Ratio (PLCR) Calculated 22.7 % 19.7-42.4
Plateletcrit (PCT) Calculated 0.39 % 0.19-0.39
Remarks : Alert!!! Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.

*Note - Mentzer index (MI), RDW-CV and RDWI are hematological indices to differentiate between Iron Deficiency Anemia (IDA) and Beta
Thalassemia Trait (BTT). MI >13, RDWI >220 and RDW-CV >14 more likely to be IDA. MI <13, RDWI <220, and RDW-CV <14 more likely
to be BTT. Suggested Clinical correlation. BTT to be confirmed with HB electrophoresis if clinically indicated.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

Sample Collected on (SCT) : 26 Dec 2024 10:16

Sample Received on (SRT) : 26 Dec 2024 12:23

Report Released on (RRT) : 26 Dec 2024 14:12

Sample Type : EDTA Whole Blood
Labcode : 2612071653/PP004 Dr Ishant Anand MD(Path)
Barcode : DC635634 Page : 2 of 10
PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159,
Bangalore

NAME : PARVATHI N(55Y/F) HOME COLLECTION :

REF. BY 129 v k gokak road Rayasandra Eshwari
: SELF
contractors 560099
TEST ASKED : WELLSENSE BASIC

TEST NAME TECHNOLOGY VALUE UNITS

25-OH VITAMIN D (TOTAL) C.M.I.A 24.6 ng/mL

Bio. Ref. Interval. :
DEFICIENCY : <10 ng/ml
INSUFFICIENCY : 10 - 30 ng/ml
SUFFICIENCY : 30 - 100 ng/ml
TOXICITY : >100 ng/ml

Method : Fully Automated Chemi Luminescent Microparticle Immunoassay

VITAMIN B-12 C.L.I.A 1226 pg/mL
Bio. Ref. Interval. :

Normal : 211 - 911 pg/ml

Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs and milk. It
is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath. Vitamin-B12 is used to find
out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For diagnostic purpose, results should always be
assessed in conjunction with the patients medical history, clinical examination and other findings.

Specifications: Intra assay (%CV):5.0%, Inter assay (%CV):9.2 %;Sensitivity:45 pg/ml

Kit Validation reference:

Chen IW, Sperling MI, Heminger LA. Vitamin B12. In: Pesce AJ, Kaplan LA, eds. Methods in Clinical Chemistry. St. Louis: CV Mosby; 1987:569–73.

Method : COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY

Please correlate with clinical conditions.

Sample Collected on (SCT) : 26 Dec 2024 10:16

Sample Received on (SRT) : 26 Dec 2024 12:29

Report Released on (RRT) : 26 Dec 2024 15:29
Sample Type : SERUM
Labcode : 2612071954/PP004 Dr Ishant Anand MD(Path)
Barcode : DC967137
Page : 3 of 10
PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159,
Bangalore

NAME : PARVATHI N(55Y/F) HOME COLLECTION :

REF. BY 129 v k gokak road Rayasandra Eshwari
: SELF
contractors 560099
TEST ASKED : WELLSENSE BASIC

TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 28.88 µg/dL

Bio. Ref. Interval. :
Male : 65 - 175
Female : 50 - 170

Method : Ferrozine method without deproteinization

TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 472.48 µg/dL
Bio. Ref. Interval. :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl

Method : Spectrophotometric Assay

% TRANSFERRIN SATURATION CALCULATED 6.11 %
Bio. Ref. Interval. :
13 - 45

Method : Derived from IRON and TIBC values

UNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 443.6 µg/dL
Bio. Ref. Interval. :
162 - 368

Method : SPECTROPHOTOMETRIC ASSAY

Please correlate with clinical conditions.

Sample Collected on (SCT) : 26 Dec 2024 10:16

Sample Received on (SRT) : 26 Dec 2024 12:29

Report Released on (RRT) : 26 Dec 2024 15:29
Sample Type : SERUM
Labcode : 2612071954/PP004 Dr Ishant Anand MD(Path)
Barcode : DC967137
Page : 4 of 10
PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159, Bangalore

NAME : PARVATHI N(55Y/F) HOME COLLECTION :

REF. BY 129 v k gokak road Rayasandra Eshwari contractors
: SELF
560099
TEST ASKED : WELLSENSE BASIC

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL CHOLESTEROL PHOTOMETRY 221 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 37 mg/dL 40-60
TRIGLYCERIDES PHOTOMETRY 127 mg/dL < 150
LDL CHOLESTEROL - DIRECT PHOTOMETRY 158 mg/dL < 100
TC/ HDL CHOLESTEROL RATIO CALCULATED 5.9 Ratio 3-5
TRIG / HDL RATIO CALCULATED 3.4 Ratio < 3.12
LDL / HDL RATIO CALCULATED 4.3 Ratio 1.5-3.5
HDL / LDL RATIO CALCULATED 0.23 Ratio > 0.40
NON-HDL CHOLESTEROL CALCULATED 183.8 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 25.4 mg/dL 5 - 40
Please correlate with clinical conditions.

Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
TRIG - Enzymatic, End Point
LDL - Direct Measure
TC/H - Derived from serum Cholesterol and Hdl values
TRI/H - Derived from TRIG and HDL Values
LDL/ - Derived from serum HDL and LDL Values
HD/LD - Derived from HDL and LDL values.
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
BORDERLINE HIGH
HIGH >240 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Collected on (SCT) : 26 Dec 2024 10:16

Sample Received on (SRT) : 26 Dec 2024 12:29
Report Released on (RRT) : 26 Dec 2024 15:29
Sample Type : SERUM
Labcode : 2612071954/PP004 Dr Ishant Anand MD(Path)

Barcode : DC967137 Page : 5 of 10

PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159, Bangalore

NAME : PARVATHI N(55Y/F) HOME COLLECTION :

REF. BY 129 v k gokak road Rayasandra Eshwari contractors
: SELF
560099
TEST ASKED : WELLSENSE BASIC

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

ALKALINE PHOSPHATASE PHOTOMETRY 107.1 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.76 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.11 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.65 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 16.3 U/L < 38
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 20.1 U/L < 31
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 14.18 U/L < 34
SGOT / SGPT RATIO CALCULATED 1.42 Ratio <2
PROTEIN - TOTAL PHOTOMETRY 8.12 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.12 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 4 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.03 Ratio 0.9 - 2
Please correlate with clinical conditions.

Method :
ALKP - Modified IFCC method
BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
OT/PT - Derived from SGOT and SGPT values.
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Collected on (SCT) : 26 Dec 2024 10:16

Sample Received on (SRT) : 26 Dec 2024 12:29
Report Released on (RRT) : 26 Dec 2024 15:29
Sample Type : SERUM
Labcode : 2612071954/PP004 Dr Ishant Anand MD(Path)

Barcode : DC967137 Page : 6 of 10

PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159, Bangalore

NAME : PARVATHI N(55Y/F) HOME COLLECTION :

REF. BY 129 v k gokak road Rayasandra Eshwari contractors
: SELF
560099
TEST ASKED : WELLSENSE BASIC

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

BLOOD UREA NITROGEN (BUN) PHOTOMETRY 9.22 mg/dL 7.94 - 20.07
CREATININE - SERUM PHOTOMETRY 0.46 mg/dL 0.55-1.02
BUN / SR.CREATININE RATIO CALCULATED 20.04 Ratio 9:1-23:1
UREA (CALCULATED) CALCULATED 19.73 mg/dL Adult : 17-43
UREA / SR.CREATININE RATIO CALCULATED 42.89 Ratio < 52
URIC ACID PHOTOMETRY 5.46 mg/dL 3.2 - 6.1
CALCIUM PHOTOMETRY 9.27 mg/dL 8.8-10.6
Please correlate with clinical conditions.

Method :
BUN - Kinetic UV Assay.
SCRE - Creatinine Enzymatic Method
B/CR - Derived from serum Bun and Creatinine values
UREAC - Derived from BUN Value.
UR/CR - Derived from UREA and Sr.Creatinine values.
URIC - Uricase / Peroxidase Method
CALC - Arsenazo III Method, End Point.

Sample Collected on (SCT) : 26 Dec 2024 10:16

Sample Received on (SRT) : 26 Dec 2024 12:29
Report Released on (RRT) : 26 Dec 2024 15:29
Sample Type : SERUM
Labcode : 2612071954/PP004 Dr Ishant Anand MD(Path)

Barcode : DC967137 Page : 7 of 10

 PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159, Bangalore

NAME : PARVATHI N(55Y/F) HOME COLLECTION :

129 v k gokak road Rayasandra Eshwari contractors
REF. BY : SELF
560099
TEST ASKED : WELLSENSE BASIC

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TSH - ULTRASENSITIVE C.M.I.A 1.627 µIU/mL 0.35-4.94

The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :

USTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay

Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Sample Collected on (SCT) : 26 Dec 2024 10:16

Sample Received on (SRT) : 26 Dec 2024 12:29
Report Released on (RRT) : 26 Dec 2024 15:29
Sample Type : SERUM
Labcode : 2612071954/PP004 Dr Ishant Anand MD(Path)
Barcode : DC967137 Page : 8 of 10
PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159, Bangalore

NAME : PARVATHI N(55Y/F) HOME COLLECTION :

REF. BY : SELF 129 v k gokak road Rayasandra Eshwari
contractors 560099
TEST ASKED : WELLSENSE BASIC

TEST NAME TECHNOLOGY VALUE UNITS

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 112 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- CKD-EPI Creatinine Equation

~~ End of report ~~

Sample Collected on (SCT) : 26 Dec 2024 10:16

Sample Received on (SRT) : 26 Dec 2024 12:29
Report Released on (RRT) : 26 Dec 2024 15:29
Sample Type : SERUM
Dr Ishant Anand MD(Path)
Labcode : 2612071954/PP004
Barcode : DC967137 Page : 9 of 10
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume: (a) any liability, responsibility for any loss or damage
that may be incurred by any person as a result of presuming the meaning or contents of the report, (b) any claims
of any nature whatsoever arising from or relating to the performance of the requested tests as well as any claim for
indirect, incidental or consequential damages. The total liability, in any case, of Thyrocare shall not exceed the
total amount of invoice for the services provided and paid for.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc

EXPLANATIONS

v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS

v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints, clinical support or feedback, write to us at [email protected]
or call us on 022-3090 0000

+ T&C Apply, #As on 5th December 2024, *As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)

Page : 10 of 10